CORDIS BRITE TIP CATHETER SHEATH INTRODUCER SYSTEM

K971608 · Cordis Corp. · DYB · Jul 21, 1997 · Cardiovascular

Device Facts

Record IDK971608
Device NameCORDIS BRITE TIP CATHETER SHEATH INTRODUCER SYSTEM
ApplicantCordis Corp.
Product CodeDYB · Cardiovascular
Decision DateJul 21, 1997
DecisionSESE
Submission TypeTraditional
Regulation21 CFR 870.1340
Device ClassClass 2

Intended Use

The modified Brite Tip® Catheter Sheath Introducer is indicated for use in arterial and venous procedures requiring percutaneous introduction of catheters and other intravascular devices. These devices provide vascular access for various intravascular devices through the valve while simultaneously maintaining hemostasis. Infusion of fluids into the vasculature and withdrawal of blood from the vasculature are possible using the sheath sideport.

Device Story

The Brite Tip® Catheter Sheath Introducer is a vascular access device used in clinical settings by physicians. It facilitates the percutaneous introduction of catheters and other intravascular devices into the arterial or venous system. The device features a valve mechanism that maintains hemostasis during the insertion and manipulation of intravascular tools. A sideport is integrated into the sheath to allow for the infusion of fluids or the withdrawal of blood. By providing a stable access point, the device enables clinicians to perform various intravascular procedures while minimizing blood loss and maintaining vascular integrity.

Clinical Evidence

No clinical data provided; biocompatibility testing was performed on device materials.

Technological Characteristics

Catheter sheath introducer system with integrated hemostasis valve and sideport for fluid infusion/blood withdrawal. Materials were subjected to biocompatibility testing.

Indications for Use

Indicated for patients undergoing arterial or venous procedures requiring percutaneous introduction of intravascular devices.

Regulatory Classification

Identification

A catheter introducer is a sheath used to facilitate placing a catheter through the skin into a vein or artery.

Predicate Devices

Related Devices

Submission Summary (Full Text)

{0}------------------------------------------------ # PREMARKET NOTIFICATION 510(k) Cordis Corporation Brite Tip® Catheter Sheath Introducer (Modification) JUL 21 1997 # SUMMARY OF SAFETY AND EFFECTIVENESS #### General Provisions l. Common or Usual Name: Catheter Sheath Introducer or Sheath Introducer Svstem Proprietary Name: Cordis Brite Tip® Catheter Sheath Introducer System #### 11. Name of Predicate Devices Brite Tip® Catheter Sheath Introducer, K 954595, October 02, 1995 ### lll. Classification Class II #### IV. Performance Standards Performance standards have not been established by the FDA under section 514 of the Food, Drug and Cosmetic Act. ### V. Intended Use and Device Description The modified Brite Tip® Catheter Sheath Introducer is indicated for use in arterial and venous procedures requiring percutaneous introduction of catheters and other intravascular devices. These devices provide vascular access for various intravascular devices through the valve while simultaneously maintaining hemostasis. Infusion of fluids into the vasculature and withdrawal of blood from the vasculature are possible using the sheath sideport. ### VI. Biocompatibility All appropriate biocompatibility tests were performed on the materials used in the modified Brite Tip® Catheter Sheath Introducer. {1}------------------------------------------------ # PREMARKET NOTIFICATION 510(k) Cordis Corporation Brite Tip® Catheter Sheath Introducer (Modification) ### Summary of Substantial Equivalence VII. The modified Cordis Brite Tip® Catheter Sheath Introducer is similar in design, construction, indication for use, and performance characteristics to other commercially available sheath introducers. A statement of substantial equivalence to another product is required by 21CFR 807.87, and relates only to whether the present product can be marketed without prior reclassification or clinical approval. The present submission is therefore not related to the coverage of any patent, and is not to be interpreted as an admission or used as evidence in a patent infringement lawsuit. As the Commissioner of the FOA has stated, "... a determination of substantial equivalence under the federal Food, Drug, and Cosmetic Act relates to the fact that the product can lawfully be marketed without pre-market approval or reclassification. This determination is not intended to have any bearing whatever on the resolution of patent infringement suits" 42 Fed. Reg. 42,520, et seg. (1977). {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is a circular emblem with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" arranged around the top half of the circle. Inside the circle is a stylized image of three human profiles facing to the right, with flowing lines beneath them. Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20856 Elena S. Jugo, M.D. Cordis Corporation P.O. Box 025700 Miami, Florida 33102-5700 JUL 2 | 1997 Re : K971608 Brite Tip® Catheter Sheath Introducer Regulatory Class: II (two) Product Code: DYB Dated: April 30, 1997 Received: May 1, 1997 Dear Dr. Juqo: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General requlation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. {3}------------------------------------------------ This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling requlation (21 CFR Part 801 and additionally 809.10 for in vitro diaqnostic devices), please contact the Office of Compliance at (301) 594-4648. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html". Sincerely yours, Thomas J. Callahon Thomas J. Callahan, Ph.D. Director Division of Cardiovascular, Respiratory, and Neuroloqical Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ Image /page/4/Picture/0 description: The image is a black and white photograph of an indiscernible object. The object is blurry and out of focus, making it difficult to identify. The background is white, which further obscures the object. # PREMARKET NOTIFICATION 510(k) Cordis Corporation Brite Tip® Catheter Sheath Introducer (Modification) 510(k) Number (if known):_____________________________________________________________________________________________________________________________________________________ Device Name: Brite Tip Catheter Sheath Introducer Indications for Use: Cordis Catheter Sheath Introducers are intended for use in arterial and venous procedures requiring percutaneous introduction of intravascular devices. PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IS NEEDED Concurrence of CDRH, Office of Device Evaluation (ODE) Ta A'R (Division Sign-Off) Division of Cardiovascular, Respiratory, and Neurological Devices 510(k) Number Prescription Use Y (Per 21 CFR 801.109) OR Over-The-Counter Use
Innolitics

Panel 1

/
Sort by
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...